ITP Registry Newsletter page 3 ITP Registry Newsletter page 3

First Page		Document Content
Date: 2009-10-12 15:30:17 Orphan drugs Idiopathic thrombocytopenic purpura Thrombocytopenia Romiplostim Platelet Splenectomy Hematology Leukemia Eltrombopag Medicine Blood Health		ITP Registry Newsletter page 3 ITP Registry Newsletter page 3 Add to Reading List Source URL: www.ouhsc.edu Download Document from Source Website File Size: 332,50 KB Share Document on Facebook

	Disponible en España romiplostim, primer estimulador de producción de plaquetas sanguíneas Romiplostim representa un importante avance en el tratamiento de la Púrpura Trombocitopénica Inmune (PTI), una rara enfermed DocID: 1sfuy - View Document
	· THROMBOCY TOPENIA · Complement Blockade with C1 Esterase Inhibitor in Refractory Immune Thrombocytopenia Erin Roesch, MD, and Catherine Broome, MD DocID: 1q1KX - View Document
	The UK Paediatric ITP Working Party UK Paediatric Chronic ITP Registry Synopsis DocID: 1g9vS - View Document
	A study of the Implementation of Romiplostim & Eltrombopag in the NHS in England Lisa 1 Cooper DocID: 1fRWP - View Document
	Amgen version datedHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Nplate safely and effectively. See full prescribing information for Nplate. x DocID: 1aGJl - View Document